Abstract
Different drug-eluting stents (DES) may have different performance in bifurcation PCI. Thus, we compared the performance of a novel zotarolimus-eluting stent (ZRS) with that obtained using two other DES in bifurcation PCI.
| Original language | English |
|---|---|
| Pages (from-to) | 122-127 |
| Number of pages | 6 |
| Journal | Cardiovascular Revascularization Medicine |
| Volume | 14 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Bifurcated lesions
- Coronary artery disease
Fingerprint
Dive into the research topics of 'Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver